Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric alphavirus replicon particles

Chimeric alphavirus replicon particles

US Patent 7531180 · Granted May 12, 2009

Estimated economic value: $39,366,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereo2022
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereo2022
Antibodies against OX-40 and uses thereof2022
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereo2022
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereo2022
Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereo2022
Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), and uses thereo2021
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereo2021
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereo2021
Antibodies against OX40 and uses thereof2020
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereo2019
Fully human antibodies to BTLA2018